VRTX EPS Estimates
Vertex Pharmaceuticals Incorporated
$488.60
-$18.40(-3.63%)
61
Overall
60
Value
60
Tech
63
Quality
Market Cap
$129.29B
Volume
530.11K
52W Range
$402.58 - $560.25
Target Price
$572.86
VRTX EPS estimates: the consensus estimate for Vertex Pharmaceuticals Incorporated's current fiscal year is $16.65 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
VRTX EPS Estimates
- EPS estimate, current quarter
- $4.28
- EPS estimate, next quarter
- $3.98
- EPS estimate, current year
- $16.65
- EPS estimate, next year
- $18.31
- EPS growth, 3-year
- +6.03%
| Fiscal year | EPS |
|---|---|
| 2025 | $15.46 |
| 2024 | $-2.08 |
| 2023 | $14.05 |
| 2022 | $12.97 |
| 2021 | $9.09 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $488.60 | -3.6% | 530.11K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW